Seit mehr als zwei Jahrzehnten ist bekannt, dass nicht nur der Tumor Nekrose Faktor-α (=TNF-α) sondern auch Lymphotoxin-α (=LTα) in Form von Trimeren an TNFR1 und TNFR2 binden kann. Durch diese Fähigkeit an beide Rezeptoren zu binden, haben diese zwei Liganden eine essentielle Rolle in der Entwicklung und dem Verlauf von Autoimmunerkrankungen. Bereits mit Beginn der 1990er Jahren wurde gezeigt, dass LTα nicht nur in Form von Homotrimeren vorliegt, sondern auch mit dem verwandten TNF-Superfamilie Liganden Lymphotoxin β (=LTβ) Heterotrimere bilden kann. Hierbei lagern sich LTα und LTβ in Form von LTα2β und LTαβ2 zusammen. Die initialen Experimente mit diesen Heterotrimeren zeigten bereits Unterschiede von LTα2β und LTαβ2. Während LTα2β wie LTα an den TNFR1 bindet, kann LTαβ2 weder an TNFR1 noch TNFR2 binden und interagiert mit einem eigenen Rezeptor namens Lymphotoxin β Rezeptor (=LTβR). Da bereits zwei Liganden (TNF und LTα) für TNFR1 und TNFR2 bekannt waren, wurde LTα2β bis heute nicht weiter charakterisiert. LTαβ2 hingegen war lange Zeit der einzige bekannte Ligand für den LTβR, weshalb die LTαβ2-LTβR-Interaktion ausführlich untersucht wurde. Diese Arbeit fokusiert sich auf die Charakterisierung von LTα2β. Hierfür wurde die einzige bekannte Eigenschaft aus den 90er Jahren von LTα2β nämlich die Bindung an TNFR1 aufgegriffen und um die Rezeptoren TNFR2 und LTβR erweitert. Diese Arbeit zeigt, dass LTα2β nicht nur an den TNFR1, sondern auch an TNFR2 und schwach an LTβR bindet. Trotz der asymmetrischen Bindestellen kann membrangebundenes LTα2β TNFR1 und TNFR2 nicht nur binden, sondern ist auch in der Lage diese zu aktivieren. Diese Arbeit gibt erste Einblicke in die Komplexizität dieses Heterotrimers indem gezeigt wird, dass LTα2β sowohl in seiner löslichen als auch in seiner membrangebundenen Form den TNFR1 aktivieren kann, während der TNFR2 nur durch das membranständige LTα2β aktiviert wird. Aufgrund der aktivierenden Eigenschaften von membranständigem LTα2β und LTαβ2 auf die murine (=mu) Panc02-Zelllinie wird ein ersten Ausblick auf mögliche weitergehende Experimente in mausbasierten Modellen gegeben. Die erzielten Ergebnisse zeigen, dass mit membranständigem LTα2β ein neuer TNFR2 Agonist gefunden wurde. / Since more than two decades it is known, that not only the Tumor Necrosis Factor-α (=TNF-α) but also lymphotoxin-a (=LTα) bind to TNFR1 and TNFR2. Because of their ability to interact with both of these two receptors, the two ligands play a crucial role in the development and persistence of autoimmune diseases. Already at the beginning of the 1990th, it has been shown that LTα forms homotrimers but is also able to form heterotrimers with the related TNF-Superfamily ligand lymphotoxin-β (=LTβ). Thereby, LTα and LTβ associate to form LTα2β and LTαβ2. Initial experiments already have shown differences between LTα2β and LTαβ2. While LTα2β can bind to TNFR1 like LTα, LTαβ2 can bind neither to TNFR1 nor to TNFR2 but interacts with its own receptor called LTβR. Due to the fact that already two ligands (LTα and TNF) for TNFR1 and TNFR2 were known, LTα2β was not further characterized. Since LTαβ2 was the only known ligand for the LTβR, this LTαβ2-LTβR interaction was further and intensively investigated. This work is focused on LTα2β and its characterization. For this purpose the initial and only finding reported for in the 1990th namely the binding to TNFR1 were taken up and expanded for the interaktion with TNFR2 and LTβR. The results of this work show that LTα2β can not only bind to TNFR1, but also to TNFR2 and weaker to LTβR. Despite its asymmetric binding sites, membrane bound LTα2β was shown not only to bind, but also to be able to activate TNFR1 and TNFR2. This work shows that LTα2β can activate the TNFR1 receptor in its soluble and membrane bound form while TNFR2 can only be activated by membrane bound LTα2β. Due to the activating properties of membrane bound LTα2β and LTαβ2 on murine (=mu) Panc02 cells a first outlook on further experiments in mouse based models will be given. These findings show, that membrane bound LTα2β is a new TNFR2 agonist.

The ability of various subsets of human mononuclear cells to produce human lymphotoxin (LT) was examined. Peripheral blood mononuclear cells were seperated into OKT4+. OKT8+ and Leu-lla+ subpopulations by flow cytometry.

Early during an immune response, dendritic cells (DC) interact closely with CD4+ T cells, and cross-talk between these cells can come in the form of tumour necrosis factor (TNF) superfamily ligand-receptor interactions. These signals are critical for the maturation, function and survival of DC, and thereby dictate the capacity of DC to prime a robust T cell response. Among these cues, helper T cell-expressed CD40L interaction with DC-expressed CD40 is required to fully mature DC for cross-priming of help-dependent CD8+ T cell responses. The lymphotoxin-beta receptor (LTβR) is another TNF family receptor on DC, and it’s ligands LTα1β2 and LIGHT are expressed on activated T cells. Since abrogated LTβR signaling impairs T cell immunity, we have examined whether LTαβ represents another possible helper T cell-derived cue for full DC maturation. However the LT pathway controls lymphoid tissue organization and DC homeostasis, a second possible mechanism explaining the necessity of LTβR signaling for T cell immunity. Here we dissect the role of helper T cell-expressed LTβR ligands and DC-intrinsic LTβR signaling, independent of DC homeostasis or lymphoid organization, in DC function and T cell immunity. Absence of LTα1β2 and not LIGHT on helper T cells results in compromised T cell priming by DC ex vivo, and LTβ-/- CD4+ T cell responses are impaired in vivo. Ag-specific CD4+ T cell-expressed LTα1β2 and DC-intrinsic LTβR signaling are required for an optimal cytotoxic T lymphocyte (CTL) response in vivo. While CD40 induces IL-12 and is required for CTL function, DC-intrinsic LTβR signaling is necessary for CTL activation and expansion, early up-regulation of CD86 and IFNα/β production. Our results reveal non-redundant roles for distinct TNF family receptors in enabling DC to program different features in Ag-specific CD8+ T cells.

Early during an immune response, dendritic cells (DC) interact closely with CD4+ T cells, and cross-talk between these cells can come in the form of tumour necrosis factor (TNF) superfamily ligand-receptor interactions. These signals are critical for the maturation, function and survival of DC, and thereby dictate the capacity of DC to prime a robust T cell response. Among these cues, helper T cell-expressed CD40L interaction with DC-expressed CD40 is required to fully mature DC for cross-priming of help-dependent CD8+ T cell responses. The lymphotoxin-beta receptor (LTβR) is another TNF family receptor on DC, and it’s ligands LTα1β2 and LIGHT are expressed on activated T cells. Since abrogated LTβR signaling impairs T cell immunity, we have examined whether LTαβ represents another possible helper T cell-derived cue for full DC maturation. However the LT pathway controls lymphoid tissue organization and DC homeostasis, a second possible mechanism explaining the necessity of LTβR signaling for T cell immunity. Here we dissect the role of helper T cell-expressed LTβR ligands and DC-intrinsic LTβR signaling, independent of DC homeostasis or lymphoid organization, in DC function and T cell immunity. Absence of LTα1β2 and not LIGHT on helper T cells results in compromised T cell priming by DC ex vivo, and LTβ-/- CD4+ T cell responses are impaired in vivo. Ag-specific CD4+ T cell-expressed LTα1β2 and DC-intrinsic LTβR signaling are required for an optimal cytotoxic T lymphocyte (CTL) response in vivo. While CD40 induces IL-12 and is required for CTL function, DC-intrinsic LTβR signaling is necessary for CTL activation and expansion, early up-regulation of CD86 and IFNα/β production. Our results reveal non-redundant roles for distinct TNF family receptors in enabling DC to program different features in Ag-specific CD8+ T cells.

Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection, predominantly experienced by children in sub-Saharan Africa. Patients with CM are comatose and often convulse, develop retinal haemorrhages and motor abnormalities. Recent histological studies on brain tissue obtained from patients who have died from CM have identified heterogeneity in brain pathology. As a result, CM is considered to be a complex disease that may be comprised of a number of syndromes. Patients admitted to hospital with CM are treated with anti-malaria drugs; however, even in the best equipped hospitals, a large number of CM patients die within the first 24-hours following hospital admission before the anti-malarial treatment can have an effect. For this reason, it is critical that the mechanisms leading to CM are elucidated in order to develop effective adjunct therapies. Experimental cerebral malaria (ECM) caused by P. berghei ANKA (PbA) infection of susceptible mice displays many features of human CM. A key feature of this model is the pivotal role of the host immune response in pathogenesis, particularly the involvement of T cells. Evidence, predominantly from ECM studies, suggests that tumour necrosis factor (TNF) superfamily (TNFSF) members play critical roles in the immunopathology associated with CM. The first hypothesis investigated in this thesis was that key immune response pathways contribute to the development of CM and, despite the heterogeneity observed between CM patients, common pathways exist that may be targeted to prevent CM. The second hypothesis tested was that members of the TNF superfamily modulate the immune response to infection and are involved in the development of pathology observed in severe malaria (SM). In order to investigate the above hypotheses, three projects were carried out. First, we examined the great heterogeneity in brain expression profiles between ECM-susceptible CBA/CaH (CBA) and C57BL/6 (B6) mice at the peak of disease, as well as the significant differences in circulating cytokine expression and expansion of microglia in brain tissue. We found that, despite these differences, common therapeutic and preventative strategies existed to disrupt the development of ECM in the two ECM-susceptible mouse strains. Second, studies in ECM mice have identified T cells and TNFSF members, TNF and lymphotoxin (LT)-a, as critical mediators of ECM pathology. We extend these studies to examine the role of the TNFSF member LIGHT in ECM. Specific blockade of LIGHT signalling through its receptor, LTβR, in PbA-infected B6 mice abrogated the hallmark features of ECM brain pathology and improved the control of parasite growth. Importantly, specific blockade of LIGHT-LTβR signalling caused the expansion of splenic monocytes and an overall enhanced capacity to remove and process antigen during infection. Together, this study discovered a novel pathogenic role for LIGHT and LTβR in ECM and identified this TNF family receptor-ligand interaction as a potential target for therapeutic intervention in SM. Finally, we investigated the role of LTa in human SM and, more specifically, CM. We tested whether the polymorphisms within the gene encoding LTa (LTA) were associated with susceptibility to SM in Papuan Highland children and adults who had migrated from an area without malaria pressure to a region where malaria is endemic. Despite a lack of association between single nucleotide polymorphisms (SNPs) in the LTA/TNF locus and susceptibility to SM in Papuan Highland children and adults, we found a significant association between a SNP in the LTa-related gene encoding galactin-2 (LGALS2) and susceptibility to CM in children, but not adults in this study population. Interestingly, no association was found between this SNP and susceptibility to CM in Tanzanian children originating from and living in a malaria endemic region. These results suggest that there may be differences in the mechanisms leading to CM in adults and children, as well as between individuals from malaria endemic and non-endemic areas. Together, the findings outlined in this thesis are important to both the understanding of the underlying mechanisms leading to CM and to the development of improved interventions and adjunct therapies.

IgE ist das Schlüsselmolekül Typ-I allergischer Erkrankungen.. Die Produktion von IgE wird durch die Interaktion des Oberflächenmoleküls CD40 auf B-Zellen mit seinem Liganden (CD40L), dass von aktivierten T-Zellen exprimiert wird, sowie über Signale durch die Zytokine IL-4 oder IL-13 von B-Zellen produziert. Die CD40/IL-4-abhängige IgE-Produktion in vitro kann einerseits als Modell zum Verständnis der Entstehung allergischer Erkrankungen eingesetzt werden; andererseits können potenziell therapeutisch wirksame Substanzen untersucht werden. Untersuchungen zum Verständnis allergischer Erkrankungen zeigen, dass LTa nach CD40/IL-4-Stimulation von humanen B-Zellen vermehrt produziert wird und dies in autokriner Weise zu einer Steigerung der CD40/IL-4-vermittelten Proliferation und IgE-Produktion führt. Darüberhinaus wurde eine vermehrte Produktion von LTa bei allergischen Patienten nachgewiesen, so dass eine funktionelle Relevanz von LTa in der Pathogenese allergischer Erkrankungen zu vermuten ist. Die Arbeiten zu den intrazellulären Mechanismen der LTa-Induktion nach CD40/IL-4-Stimulation demonstrieren, dass sowohl der Transkriptionsfaktor NF-kB als auch verschiedene Proteinkinasen hier eine wesentliche Rolle spielen. Untersuchungen mit Hilfe des CD40/IL-4-abhängigen Systems bei humanen B-Zellen, die einen therapeutischen Einsatz zur Behandlung allergischer Erkrankungen haben könnten, zeigen, dass Retinoide aber auch Vitamin D zu einer erheblichen Hemmung der IgE-Produktion in- vitro führen. / IgE plays a key role for the development of type I related allergic diseases. Production of IgE by B cells is induced by the interaction of the surface molecule CD40 with its natural ligand (CD40L), which is expressed on activated T cells and signals which are provided by the cytokines IL-4 or IL-13. This model can be used for studies either to understand the development of allergic diseases or to investigate novel therapeutic approaches. In the context of the understanding the development of allergic diseases the present work shows that LTa is produced by B cells after CD40+IL-4 stimulation and that increased production of LTa results in enhanced CD40+IL-4 mediated B cell proliferation and IgE synthesis. Furthermore an increased production of LTa was shown in allergic patients indicating the potential role of LTa in allergic diseases. Analysis of the gene regulation of LTa after CD40 stimulation revealed an important role of the transcription factor NF-kB and showed the role of different protein kinases at the intracellular level. Studies using the CD40+IL-4 system in vitro which may have a therapeutical impact revealed that vitamin A and vitamin D are potent inhibitors of IgE production in vitro. Taken together the present work shows new mechanisms of CD40+IL-4 mediated IgE synthesis and also offers new potential therapeutical approaches of allergic diseases.

The mammalian immune system has developed diverse strategies to protect the gastrointestinal tract, as this tissue locale represents a huge absorptive surface and is susceptible to microbial breach. Paradoxically, one key aspect of this protective strategy is the maintenance of selected commensal microorganisms. These commensals serve essential roles in digestion, interfere with pathogenic microbial invasion and stimulate development of the host immune system. Therefore, immune responses which deplete these commensal populations are detrimental to the host. One effective intestinal immune response which selectively promotes the survival of commensals is production of antibodies of the IgA isotype which bind to bacteria without triggering inflammatory cytokines. Proteins of the tumor necrosis factor (TNF) family such as Lymphotoxin and BAFF contribute to the induction of IgA responses. Lymphotoxin is required for generation and organization of most organized lymphoid tissues, where B cell differentiation occurs, while BAFF is necessary for B cell survival and induces B cells to produce IgA. In this thesis, I describe work I have done in examining the roles of the TNF family members Lymphotoxin, BAFF and two related TNF family member cytokines, LIGHT and APRIL, in the regulation of IgA production in mice and in humans. Specifically, LIGHT over-expression drives immense production of IgA, leading to renal deposition of immune complexes in mice. Similar to LIGHT, BAFF over-expression drives increases in IgA production in the intestine, however I have shown that the effects of the BAFF pathway on IgA hyper-production are independent of LIGHT activity. Secondly, examining the phenotype of BAFF-over-expressing mice, I have shown that this phenotype resembles human IgA nephropathy (IgAN) and is dependent on intestinal commensals. Finally, I have described a lymphotoxin-dependent chemokine system in the intestinal lamina propria that could be responsible for organizing cells for the development of IgA responses in this mucosal site.

The mammalian immune system has developed diverse strategies to protect the gastrointestinal tract, as this tissue locale represents a huge absorptive surface and is susceptible to microbial breach. Paradoxically, one key aspect of this protective strategy is the maintenance of selected commensal microorganisms. These commensals serve essential roles in digestion, interfere with pathogenic microbial invasion and stimulate development of the host immune system. Therefore, immune responses which deplete these commensal populations are detrimental to the host. One effective intestinal immune response which selectively promotes the survival of commensals is production of antibodies of the IgA isotype which bind to bacteria without triggering inflammatory cytokines. Proteins of the tumor necrosis factor (TNF) family such as Lymphotoxin and BAFF contribute to the induction of IgA responses. Lymphotoxin is required for generation and organization of most organized lymphoid tissues, where B cell differentiation occurs, while BAFF is necessary for B cell survival and induces B cells to produce IgA. In this thesis, I describe work I have done in examining the roles of the TNF family members Lymphotoxin, BAFF and two related TNF family member cytokines, LIGHT and APRIL, in the regulation of IgA production in mice and in humans. Specifically, LIGHT over-expression drives immense production of IgA, leading to renal deposition of immune complexes in mice. Similar to LIGHT, BAFF over-expression drives increases in IgA production in the intestine, however I have shown that the effects of the BAFF pathway on IgA hyper-production are independent of LIGHT activity. Secondly, examining the phenotype of BAFF-over-expressing mice, I have shown that this phenotype resembles human IgA nephropathy (IgAN) and is dependent on intestinal commensals. Finally, I have described a lymphotoxin-dependent chemokine system in the intestinal lamina propria that could be responsible for organizing cells for the development of IgA responses in this mucosal site.

Die kontinuierliche Rezirkulation von Immunzellen durch periphere und sekundäre lymphatische Organe (SLOs) ist Bestandteil der Immunüberwachung und wichtig für die Aufrechterhaltung und Funktionsbereitschaft des Immunsystems. Der homöostatische Chemokinrezeptor CCR7 vermittelt dabei nicht nur die Rezirkulation von Lymphozyten durch SLOs, sondern scheint auch an der homöostatischen Rezirkulation von Lymphozyten durch nicht-lymphoide periphere Gewebe beteiligt zu sein. Im Rahmen dieser Arbeit wurde mithilfe von CCR7-defizienten Mäusen die funktionale Bedeutung von CCR7 für die homöostatische Rezirkulation von Lymphozyten durch das Peritoneum untersucht und nachgewiesen, dass CCR7 der dominante Chemokinrezeptor ist, der unter physiologischen Bedingungen die Transitzeit von Lymphozyten durch das Peritoneum festlegt. Die gestörte Rezirkulation von Lymphozyten begünstigte außerdem die Entstehung von tertiären lymphoiden Organen (TLOs) in der Magenschleimhaut von CCR7-defizienten Mäusen. Untersuchungen zur zellulären und molekularen Grundlage dieser und weiterer pathomorphologischer Veränderungen in der Magenschleimhaut von CCR7-defizienten Mäusen verdeutlichten die Funktion von CCR7 für die Etablierung von zentraler und peripherer Toleranz gegenüber gastrischen Antigenen. Fehlt CCR7, dann entwickelten Mäuse eine spontane Autoimmungastritis, welche durch gastritogene CD4+ T-Zellen verursacht wurde, deren Aktivierung auch unabhängig von Lymphknoten und TLOs erfolgte. Die Entstehung von TLOs wird auch bei einer durch Helicobacter pylori ausgelösten chronischen Gastritis beobachtet. Die Expression des homöostatischen Chemokinrezeptors CXCR5 und seines Liganden CXCL13 ist mit der Entwicklung dieser TLOs korreliert worden. Unter Verwendung eines Mausmodells für H. pylori-induzierte chronische Gastritis konnte gezeigt werden, dass CXCR5 die Ausbildung von TLOs vermittelt und eine Rolle für die Induktion von H. pylori-spezifischen T-Zell- sowie humoralen Immunantworten spielt. / Homeostatic recirculation of immune cells through peripheral and secondary lympoid organs (SLOs) is required for immune surveillance and the maintenance and functionality of the immune system. The homeostatic chemokine receptor CCR7 controls not only lymphoid cell trafficking to and within SLOs, but also seems to be involved in the homeostatic recirculation of lymphocytes through non-lymphoid peripheral tissues. Within the scope of this work we investigated the functional relevance of CCR7 for the homeostatic recirculation of lymphocytes through the peritoneal cavity and could show, that CCR7 is the dominant chemokine receptor which defines the transit time of lymphocytes in the peritoneal cavity under physiological conditions. Impaired recirculation of lymphocytes also promoted the development of tertiary lymphoid organs (TLOs) in the gastric mucosa of CCR7-deficient mice. Analysis of the cellular and molecular mechanisms underlying these and other pathomorphological alterations in the gastric mucosa of CCR7-deficient mice provided further evidence regarding the function of CCR7 for the establishment of central and peripheral tolerance towards gastric antigens. Mice that lack CCR7 spontaneously developed autoimmune gastritis, which was caused by gastritogenic CD4+ T-cells. Such autoreactive T cell responses were also initiated in the absence of lymph nodes and TLOs in CCR7/LT-alpha double-deficient mice. Development of TLOs is also observed during chronic gastritis induced by Helicobacter pylori. The expression of the homeostatic chemokine receptor CXCR5 and its ligand CXCL13 has been correlated with the development of these TLOs. Using a mouse model for H. pylori-induced chronic gastritis, we could show that CXCR5 is responsible for the development of TLOs and also plays a role for the induction of H. pylori-specific T and B cell responses.

LIGHT, un membre de la famille du TNF, déclenche la mort des motoneurones et contribue à la progression de la dégénérescence des motoneurones chez les souris modèles de la sclérose latérale amyotrophique. Étonnement, nous montrons que LIGHT peut également stimuler la croissance axonale in vitro et est nécessaire à la régénération axonale des motoneurones in vivo lors d'une lésion nerveuse périphérique. La compréhension des mécanismes dictant la bivalence de son récepteur mène à l'étude des effets de la régionalisation du signal LIGHT. Les chambres microfluidiques en isolant les axones des corps cellulaires, nous ont permis d'étudier la résultante fonctionnelle d'une stimulation axonale et somatique par LIGHT. Nous montrons que LIGHT active différentiellement la mort, quand il agit au niveau somatique, ou la régénération axonale, quand il stimule l'axone. L'ensemble de ces résultats mène à de nouvelles approches où l'administration de LIGHT au niveau du nerf lésé et du muscle correspondant nous renseignera sur le potentiel thérapeutique de LIGHT lors d'une lésion du système nerveux. / LIGHT, a member of the TNF superfamily, triggers death of motoneurons and contribute to the progression of motoneuron degeneration in an ALS mouse model. Interestingly, we demonstrate that LIGHT can elicit neurite outgrowth in vitro and contribute to axon regeneration in vivo following nerve injury. To better understand mechanisms governing the opposite effects of LIGHT on motoneurons we asked whether a regional activation of LIGHT pathway could trigger these opposite responses. Toward this goal we used microfluidic chambers to isolate the soma from the axon of motoneurons. We shows that LIGHT activates differentially motoneurons death when it acts at the soma and axon outgrowth when it acts at the level of the axon. Together, these results lead us to evaluate new therapeutic approaches to nerve injury.